Molecular Strategies to Target Protein Aggregation in Huntington’s Disease

• Published in: Frontiers in molecular biosciences 2021-11, Vol.8, p.769184-769184
• Main Authors: Jarosińska, Olga D., Rüdiger, Stefan G. D.
• Format: Article
• Language: English
• Subjects: aggregation; huntingtin (HTT); Molecular Biosciences; protein degradation; protein fibrils; protein quality control; proteostasis
• ISSN: 2296-889X; 2296-889X
• DOI: 10.3389/fmolb.2021.769184

Huntington’s disease (HD) is a neurodegenerative disorder caused by the aggregation of the mutant huntingtin (mHTT) protein in nerve cells. mHTT self-aggregates to form soluble oligomers and insoluble fibrils, which interfere in a number of key cellular functions. This leads to cell quiescence and ultimately cell death. There are currently still no treatments available for HD, but approaches targeting the HTT levels offer systematic, mechanism-driven routes towards curing HD and other neurodegenerative diseases. This review summarizes the current state of knowledge of the mRNA targeting approaches such as antisense oligonucleotides and RNAi system; and the novel methods targeting mHTT and aggregates for degradation via the ubiquitin proteasome or the autophagy-lysosomal systems. These methods include the proteolysis-targeting chimera, Trim-Away, autophagosome-tethering compound, autophagy-targeting chimera, lysosome-targeting chimera and approach targeting mHTT for chaperone-mediated autophagy. These molecular strategies provide a knowledge-based approach to target HD and other neurodegenerative diseases at the origin.